Form 4: Prestige Consumer Healthcare SVP Mary Beth Fritz Reports Stock Option Exercise and Sale
SEC Form 4
Mary Beth Fritz, SVP of Quality & Regulatory at Prestige Consumer Healthcare Inc., reports exercising stock options and selling shares on February 23 and 26, 2024.
Summary
- Mary Beth Fritz, SVP of Quality & Regulatory at Prestige Consumer Healthcare Inc., filed a Form 4 detailing changes in beneficial ownership.
- On February 23, 2024, Fritz exercised options to acquire 12 shares at $57.18 and 11 shares at $30.56, and then sold 12 shares and 11 shares at $70.
- On February 26, 2024, Fritz exercised options to acquire 5,132 shares at $57.18 and 4,545 shares at $30.56, and then sold 5,132 shares at a weighted average price of $70.43 and 4,545 shares at a weighted average price of $70.44.
- Following these transactions, Fritz directly owns 15,934 shares of Prestige Consumer Healthcare Inc.
- The transactions were executed pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine transaction under a pre-arranged plan. The executive is realizing gains from stock options, which is neither overly positive nor negative.
Positives
- The transactions were executed under a pre-arranged trading plan (Rule 10b5-1(c)), which can mitigate concerns about insider trading.
Industry Context
Executive stock transactions are common and are monitored by investors to gauge sentiment and potential future performance. Rule 10b5-1 plans are often used to schedule transactions in advance to avoid insider trading concerns.
Comparison to Industry Standards
- Executive compensation packages often include stock options as incentives.
- The exercise and sale of shares are typical activities for executives holding such options.
- The use of Rule 10b5-1 plans is a standard practice to ensure compliance with insider trading regulations.
- Comparing the volume and frequency of these transactions with peers in the consumer healthcare industry could provide further insights.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders.
- Shareholders may view the transactions as a routine part of executive compensation.
Key Dates
| Date | Description |
|---|---|
| 05/09/2017 | First vesting date for 1,817 shares of employee stock options at $57.18 |
| 05/09/2018 | Second vesting date for 1,818 shares of employee stock options at $57.18 |
| 05/09/2019 | Third vesting date for 1,818 shares of employee stock options at $57.18 |
| 05/06/2020 | First vesting date for 2,540 shares of employee stock options at $30.56 |
| 05/06/2021 | Second vesting date for 2,541 shares of employee stock options at $30.56 |
| 05/06/2022 | Third vesting date for 2,541 shares of employee stock options at $30.56 |
| 02/23/2024 | Fritz exercised options and sold shares |
| 02/26/2024 | Fritz exercised options and sold shares |
| 02/27/2024 | Date of Form 4 filing |
| 05/09/2026 | Expiration date for employee stock options at $57.18 |
| 05/06/2029 | Expiration date for employee stock options at $30.56 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.